Ohya Y, et al. Japanes Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (in Japanese). Japanese Soc Hypertens. 2025. (in press).

NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–51.

PubMed Central  Google Scholar 

Akasaki Y, Suematsu Y, Azushima K, Shiga Y, Sakima A, Satoh M, et al. Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis. Hypertens Res. 2025;48:1827–38. https://doi.org/10.1038/s41440-025-02152-9.

Article  PubMed  PubMed Central  Google Scholar 

Kario K & Ohya Y. Synchronizing science and society: JSH2025 Guidelines × “Asakatsu BP” action – Morning Blood Pressure 130 Campaign. Hypertens Res. (2025). https://doi.org/10.1038/s41440-025-02295-9.

Maruhashi T, Tatsumi Y, Satoh M, Kobayashi Y, Ogoyama Y, Sakima A, et al. Updated meta-analysis for antihypertensive treatment guided by home blood pressure compared to treatment based on office blood pressure: systematic review. Hypertens Res. 2025;48:1839–45. https://doi.org/10.1038/s41440-024-02072-0.

Article  PubMed  Google Scholar 

Haze T, Katsurada K, Sakata S, Kuwabara M, Nishida N, Azegami T, et al. Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis. Hypertens Res. 2025;48:1846–58. https://doi.org/10.1038/s41440-025-02131-0.

Article  PubMed  Google Scholar 

Maeda T, Ohya Y, Ishida S, Inoue Y, Fujii T, Sakamoto Y, et al. Optimal blood pressure target for patients with prior stroke: A systematic review and meta-analysis. Hypertens Res. 2025;48:1859–69. https://doi.org/10.1038/s41440-025-02183-2.

Article  PubMed  Google Scholar 

Matsumoto C, Nagai M, Shinohara K, Morikawa N, Kai H, Arima H. Systolic blood pressure lower than 130 mmHg in heart failure with preserved ejection fraction: a systematic review and meta-analysis of clinical outcomes. Hypertens Res. 2025;48:2138–51. https://doi.org/10.1038/s41440-025-02240-w.

Article  Google Scholar 

Tada K, Fujiwara A, Sugano N, Hayashi K, Sakima A, Takami Y, et al. Evaluating blood pressure targets in chronic kidney disease: a systematic review and meta-analysis. Hypertens Res. 2025. https://doi.org/10.1038/s41440-025-02262-4. Online ahead of print.

Abe M, Segawa H, Kinguchi S, Satoh A, Zamami R, Nishikido T, et al. Intensive blood pressure-lowering treatment to prevent cardiovascular events in patients with diabetes: a systematic review and meta-analysis. Hypertens Res. 2025;48:2024–33. https://doi.org/10.1038/s41440-025-02209-9.

Article  PubMed  Google Scholar 

Ichikawa D, Kawarazaki W, Saka S, Kanaoka T, Ohnishi H, Arima H, et al. Efficacy of renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in hypertensive patients with diabetes: subgroup analysis based on albuminuria in a systematic review and meta-analysis. Hypertens Res. 2025;48:1880–90. https://doi.org/10.1038/s41440-025-02146-7.

Article  PubMed  Google Scholar 

Nozato Y et al. Targeting a systolic blood pressure of <130 mmHg is beneficial in adults with hypertension aged ≥75 years: a systematic review and meta-analysis. Hypertens Res (in press).